5
Views
7
CrossRef citations to date
0
Altmetric
Journal Article

Hypothesis: possible role of magnesium and calcium in the development of structure and function of the plasma membrane in mammalian cells and in human diseases.

Pages 410-425 | Published online: 02 Sep 2013

References

  • Durlach J: Recommended dietary amounts of magnesium: Mg RDA. Magnesium Research 2: 195–203. 1989.
  • Kubena KS, Durlach J: Historical review of the effects of marginal intake of magnesium in chronic experimental magnesium deficiency. Magnesium Research 3: 219–226, 1990.
  • Lakshmanan FL, Rao RB, Kim WW, Kelsay JH: Magnesium intake, balance and blood levels of adults consuming self-selected diets. Am J Clin Nutr 40: 1380–1389, 1984.
  • Seelig MS: Requirement of magnesium by the normal adult. Am J Clin Nutr 14: 342–390, 1964.
  • Araurke N, Tokio K: Protein turnover in the cell cycle of Escherichia coli. J Bacteriol 90: 984–989, 1965.
  • Chuman L, Fine LG, Cohen AH, Saier MH: Growth of toximal tubular kidney epithelial cells in hormone-supplemented serum free medium. J Cell Biol 94: 506–510, 1982.
  • Aikawa JK: “Magnesium: Its Biological Significance.” Boca Raton, FL: CRC Press, 1981.
  • Oro J: Prebiological chemistry and the origin of life. In Kornberg A, Horecker BL, Cornudella L, Oro J (eds): “Reflections on Biochemistry.” New York: Pergamon Press, pp 431, 1976.
  • Orgel LE: “The Origins of Life: Molecules and Natural Selection.” New York: John Wiley and Sons, 1973.
  • Oparin AI: “Genesis and Evolutionary Development of Life.” New York: Academic Press, 1968.
  • Lehninger AL: The origin of life. In: “Biochemistry,” 3rd ed. New York: Worth Publishers, pp 1031–1057, 1975.
  • de Duve C: “Blueprint for a Cell: The Nature and Origin of Life.” Burlington: Neil Patterson, p 115, 1991.
  • Woese C: “The Genetic Code: The Molecular Basis for Genetic Expression.” New York: Harper and Row, 1967.
  • Mann C, Margulis L: Science's unruly Earth Mother. Science 252: 378–381, 1991.
  • Horgan J: In the beginning. Sci Am 264: 116–125, 1991.
  • Van der Leeden F, Troise FL, Todd DK: “The Water Encyclopedia.” Chelsea, Michigan: Lewis Publishers, pp 238, 422, 1990.
  • Hawk PB, Bergeim O: “Practical Physiological Chemistry,” 11th ed. Philadelphia: Blakiston's Son and Company, pp 468–474, 1937.
  • Grosshans CA, Cech TR: Metal ion requirements for sequence-specific endoribonuclease activity of the tetrahymena ribozyme. Biochemistry 28: 6888–6894, 1989.
  • Heaton FW: Magnesium in intermediary metabolism. In Cantin M, Seelig MS (eds): “Magnesium in Health and Disease.” New York: Spectrum Press, pp 43–55, 1980.
  • Jaenick R: Protein folding: local structures, domains, sub-units, and assemblies. Biochemistry 30: 3147–3153, 1991.
  • Kawata Y, Hamaguchi K: Use of fluorescence energy transfer to characterize the compactness of the constant fragment of an immunoglobulin light chain in the early stage of folding. Biochemistry 30: 4367–4373, 1991.
  • Raetz CRH: Molecular genetics of membrane phospholipid synthesis. Annu Rev Genet 20: 253–295, 1986.
  • Raetz CRH, Dowhan W: Biosynthesis and function of phospholipids in Escherichia coli. J Biol Chem 265: 1235–1238, 1990.
  • Tai SP, Kaplan S: Purification and properties of a phospholipid transfer protein from Rhodopseudomonas sphaeroides. J Biol Chem 259: 12178–12183, 1984.
  • Donohue TJ, Cain BD, Kaplan S: Alteration in the phospholipid composition of Rhodopseudomonas sphaeroides and other bacteria induced by tris. J Bacteriol 152: 595–606, 1982.
  • Kaplan S, Arntzen CJ: Photosythetic membrane structure and function. In Govindjee (ed): “Photosynthesis.” New York: Academic Press, pp 65–152, 1982.
  • Kaplan S: Development of the membranes of photosynthetic bacteria. Photochem Photobiol 34: 769–774, 1981.
  • Danson MJ: Archaebacteria the comparative enzymology of their central metabolic pathways from advances. In Rose HH, Tempest DW (eds): “Microbiol Physiology.” New York: Academic Press, 29: 106–223, 1988.
  • Zillis W, Palm P, Reiter WD, Gropp F, Puklar G, Klenk K: Comparative evaluation of gene expression in Archaebacteria. Eur J Biochem 173: 473–482, 1988.
  • Gordon JI, Duronio RJ, Rudnick DA, Adams SP, Gokel GW: Protein N-Myristoylation. J Biol Chem 266: 8647–8656, 1991.
  • Valencia A, Chardin P, Wittinghofer A, Sander C: The ras protein family: evolutionary tree and role of conserved amino acids. Biochemistry 30: 4637–4830, 1991.
  • Mahfouz MM, Smith TL, Kummerow FA: Changes in phospholipid composition and calcium flux in LLC-PK cells cultured at low magnesium concentrations. Biochim Biophys Acta 1006: 75–83, 1989.
  • Mahfouz MM, Smith TL, Kummerow FA: Changes of linoleic acid metabolism and cellular phospholipid fatty acid composition in LLC-PK cells at low magnesium concentrations. Biochim Biophys Acta 1006: 70–74, 1989.
  • Yeagle PL: Cholesterol and the cell membrane. Biochim Biophys Acta 822: 267–287, 1985.
  • Yeagle PL: “The Membranes of Cells.” New York: Academic Press, 1987.
  • Smith E, Ashall C: Low density lipoprotein concentration in interstitial fluid from human atherosclerosis lesions. Biochim Biophys Acta 754: 249–257, 1983.
  • Jacobus WE, Moreadith RW, Vandegaer KW: Control of heart oxidation phosphorylation by creating kinase in mitochondrial membranes. In Kummerow FA, Benge G, Holmes RP (eds): “Biomembranes and Cell Function.” Ann NY Acad Sci 414: 73–89, 1983.
  • Prosser CL: “Molecules to Organisms in Adaptational Biology.” New York: John Wiley and Sons, 1986.
  • Bloch K: Cholesterol evolution of structure and function. In Vance DE, Vance JE (eds): “Biochemistry of the Lipids and Membranes.” Menlo Park: The Benjamin/Cummings Publishing Co, pp 1–22, 1985.
  • Dempsey ME: Regulation of steroid biosynthesis. In Boyer PD, Meister A, Richarson CC (eds): “Annual Review of Biochemistry.” Palo Alto: Ann Rev Inc, 43: 967–990, 1974.
  • Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan J, Hoogsteen K, Liesch J, Springer J: Mevinolin a highly potent competitive inhibitor of hydroxy methyl glutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 77: 3957–3961, 1980.
  • Walker B, Kummerow FA: Erythrocyte fatty acid composition and apparent permeability to non-electrolytes. Proc Soc Exp Biol Med 115: 1099–1103, 1964.
  • Von Heije G: Sequence determinants of protein sorting into and across membranes. In den Kemp J Op (ed): “Membrane Biogenesis.” New York: Springer-Verlag, pp 308–322, 1988.
  • Kummerow FA: Factors which may alter the assembly of biomembranes so as to influence their structure or function. In Kemp JAF (ed): “Membrane Biogenesis.” New York: Springer Verlag, pp 85–102, 1987.
  • Zhou Q, Jimi S, Smith TL, Kummerow FA: The effect of cholesterol on the accumulation of intracellular calcium. Biochim Biophys Acta 1086: 1–6, 1991.
  • Grunze M, Forst B, Deuticke B: Dual effect of membrane cholesterol on simple and mediated transport processes in human erythrocytes. Biochim Biophys Acta 600: 860–869, 1980.
  • Masiak SJ, LeFevre PG: Effects of membrane steroid modification on human erythrocyte glucose transport. Arch Biochem Biophys 162: 442–444, 1974.
  • El-Say MY, Guion TA, Fayer MD: Effect of cholesterol on viscoelastic properties of dipalmitoylphosphatidylcholine multibilayers as measured by a laser-induced ultrasonic probe. Biochemistry 25: 4825–4832, 1986.
  • Jacobs R, Oldfield E: Deuterium nuclear magnetic resonance investigation of dimyristoyllecithin-dipalmitoyllecithin and dimyristoyllecithin-cholesterol mixtures. Biochemistry 18: 3280–3285, 1979.
  • Demel PA: “Biophysics of Membrane Transport-School Proceedings of the Fifth Winter School on Biophysics of Membrane Transport,” Vol 1. Poland: University of Wroclaw, pp 267–272, 1979.
  • Hubbell WL, McConnell HM: Molecular motion in spin-labeled phospholipids and membranes. J Am Chem Soc 93: 314–326, 1971.
  • Oldfield E, Chapman D: Effects of cholesterol and cholesterol derivatives on hydrocarbon chain mobility in lipids. Biochem Biophys Res Commun 43: 610–616, 1971.
  • Whetton AD, Houslay MD: 5′-nucleotidase is activated upon cholesterol-depletion of liver plasma membranes. FEBS Lett 157: 70–74, 1983.
  • Vincent M, Gallay J: Time-resolved fluorescence anisotrophy study of effect of cis double bond in structure of lecithin and cholesterol-lecithin bilayers using n-(9-anthroxyloxy) fatty acids as probes. Biochemistry 23: 6514–6522, 1984.
  • Van Blitterswijk WJ, Van Hoeven RP, Van Der Meer BW: Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim Biophys Acta 644: 323–332, 1981.
  • Kummerow FA, Smith TL, Mahfouz MM, Pikul J: Dietary fat and plasma lipid physical properties in swine. J Am Coll Nutr 104: 360–369, 1991.
  • Rizek RL, Welsh SO, Marston RM, Jackson EM: Levels and sources of fat in the U.S. food supply and in diets of individuals. In Perkins E, Viskek W (eds): “Dietary Fats and Health.” Urbana, IL: Am Oil Chemists' Society, pp 13–43, 1983.
  • Carpenter DL, Slover HT: Lipid composition of selected margarines. J Am Oil Chem Soc 50: 372–376, 1973.
  • Enig MG, Atal S, Keeney M, Sampugna J: Isometric trans fatty acids in the U.S. diet. J Am Coll Nutr 9: 471–486, 1990.
  • Grundy S, Vega LG: Plasma cholesterol responsiveness to saturated fatty acids. Am J Clin Nutr 47: 822–824, 1988.
  • Kummerow FA: Effects of isomeric fats on animal tissue, lipid classes and atherosclerosis. In Emken EA, Dutton HJ (eds): “Geometrical and Positional Fatty Acid Isomers.” Champaign, IL: Am Oil Chemists' Society, pp 151–175, 1979.
  • Mahfouz MM, Smith TL, Kummerow FA: Effect of dietary fats on desaturase activities and the biosynthesis of fatty acids in rat-liver microsomes. Lipids 19: 214–222, 1984.
  • Locher R, Neyses L, Stimpel M, Kuffer B, Vetter W: The cholesterol content of the human erythrocyte influences calcium influx through the channel. Biochem Biophys Res Commun 124: 822–828, 1984.
  • Gleason MM, Medow MS, Tulenko TN: Excess cholesterol alters calcium fluxes and membrane fluidity in cultured arterial smooth muscle cells. Arteriosclerosis 9: 693a, 1989.
  • Storch J, Schachter D: Calcium alters the acyl chain composition and lipid fluidity of rat hepatocyte plasma membranes in vitro. Biochim Biophys Acta 812: 473–484, 1985.
  • Ortega A, Mas-Oliva J: Direct regulatory effect of cholesterol on the calmodulin stimulated calcium pump of cardiac sarcolemma. Biochem Biophys Res Commun 139: 868–874, 1986.
  • Abeywardena MY, McMurchie EJ, Russell GR, Sawyer WH, Charnock JS: Response of rat heart membranes and associated ion-transporting ATPases to dietary lipid. Biochim Biophys Acta 776: 48–59, 1984.
  • Kou I-L, Pikul J, Kummerow FA: Influence of 26-hydroxycholesterol on the composition and function of gel-filtered platelets. J Am Coll Nutr 10: 114–122, 1991.
  • Jimi S, Smith TL, Kummerow FA: 26-hydroxycholesterol-stimulated DNA synthesis in smooth muscle cells and induction of endothelial injury using a coculture technique. Biochem Med Metab Biol 44: 114–125, 1990.
  • Zhou Q, Jimi S, Smith TL, Kummerow FA: The effect of 25-hydroxy cholesterol on accumulation of intracellular calcium. Cell Calcium 12: 467–476, 1991.
  • Rayssiguier Y, Gueux E, Weiser D: Effect of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet. J Nutr 111: 1876–1883, 1981.
  • Rayssiguier Y: New data on magnesium and lipids interrelationships in pathogenesis of vascular diseases in magnesium deficiency. In Halpern MJ, Durlach J (eds): “Physiopathology and Treatment Implications.” New York: Karger, pp 122–131, 1985.
  • Mahfouz MM, Smith TL, Kummerow FA: Decreased uptake of low density lipoprotein by LLC-PK cells cultured at low magnesium concentration. Magnesium, submitted.
  • Mahfouz MM, Kummerow FA: Effect of magnesium deficiency on delta desaturase activity and fatty acid composition of rat liver microsomes. Lipids 24: 727–732, 1989.
  • Rayssiguier Y, Gueux E, Cardot P, Thomas G, Robert A, Trugnan G: Variations of fatty acid composition in plasma lipids and platelet aggregation in magnesium deficient rats. Nutr Res 6: 233–240, 1986.
  • Durlach J: Chronic tetany and magnesium deficiency. Lancet 1: 282–283, 1961.
  • Galland L: Impaired essential fatty acid metabolism in latent tetany. Magnesium 4: 333–338, 1985.
  • Spector A, Yorek M: Membrane lipid composition and cellular function. J Lipid Res 26: 1015–1035, 1985.
  • Gueux E, Rayssiguier Y: The hypercholesterolemic effect of magnesium deficiency following cholesterol feeding in the rat. Magnesium Bull 3: 126–129, 1981.
  • Schwartz R, Woodcock MA, Blakely SD, Wong FL, Khavrallah EA: Effect of magnesium in growing rats on synthesis of liver protein and serum albumin. J Nutr 97: 123–128, 1970.
  • Jaya P, Kurup PA: Magnesium deficiency and metabolism of Lipids in rats fed cholesterol-free and cholesterol-containing diet. Indian J Biochem Biophys 24: 92–95, 1987.
  • Tongyai A, Rayssiguier Y, Motta A, Gueux E, Maurois P, Heaton F: Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats. Am J Physiol 257: 270–276, 1989.
  • Rayssiguier Y, Gueux E, Motta C: Magnesium deficiency effect on fluidity and function of plasma and subcellular membranes. In Lassene B, Durlach J (eds): “Magnesium: A Relevant Ion.” London: John Libbey, pp 311–319, 1991.
  • Rayssiguier Y, Mazur A, Cardot P, Gueux E: Effects of Mg on lipid metabolism and cardiovascular disease. In Itokawa Y, Durlach J (eds): “Magnesium in Health and Disease.” London: John Libbey, pp 199–207, 1989.
  • Gueux E, Mazur A, Cardot P, Rayssiguier Y: Magnesium deficiency affects plasma lipoprotein composition in rats. J Nutr 121: 1222–1227, 1991.
  • Rayssiguier Y, Noe L, Etienne J, Gueux E, Cardot P, Mazur A: Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rat. Lipids 26: 182–186, 1991.
  • Gunther TH: Magnesium deficiency generally enhances cytotoxicity. Magnesium Bull 3: 91–101, 1981.
  • Flink EB, Brick JE, Shane SR: Alterations of long chain free fatty acid and magnesium concentrations in acute myocardial infarction. Arch Intern Med 141: 441–443, 1981.
  • Reyes AJ, Leary WP: Diuretic therapy, magnesium deficiency and lipid metabolism. S Afr Med J 64: 355–356, 1983.
  • Itokawa Y, Sasagawa S, Fujiwara M: Effects of thiamine on lipid metabolism in magnesium deficient rats. J Nutr Sci Vitaminol 19: 15–21, 1973.
  • Crompton M, Moser R, Ludi H, Carafoli E: The interrelations between the transport of sodium and calcium in mitochondria of various mammalian tissues. Eur J Biochem 82: 25–31, 1978.
  • Murphy E, Coll K, Rich TL, Williamson JR: Hormonal effects on calcium homeostasis in isolated hepatocytes. J Biol Chem 255: 6600–6608, 1980.
  • Nigam S, Averdunk R, Gunther T: Alteration of prostanoid metabolism in rats with magnesium deficiency. Leuk Pros-tagland Med 23: 1–10, 1986.
  • Rey PS, McCord JM: Superoxide and ischemia in conversion of xanthine dehydrogenase to xanthine oxidase. In Greenwald R, Cohen G (eds): “Proceedings of the 3rd International Conference on Superoxide and Superoxide Dismutase.” New York: Elseviers, pp 145–153, 1983.
  • Dean PJ: The role of oxygen concentrations in oxidative stress: Hypoxic and hyperoxic models. In Helmut S (ed): “Oxidative Stress.” New York: Academic Press, pp 152–189, 1985.
  • Seelig MS: “Magnesium Deficiency in the Pathogenesis of Disease.” New York: Plenum, p 1, 1980.
  • Altura BT, Altura BM: The role of magnesium in etiology of stroke and cerebrovasospasm. Magnesium 1: 227–291, 1982.
  • Altura BM, Altura BT, Carella A: Magnesium deficiency-induced spasms of umbilical vessels: relation to preeclampsia, hypertension, and growth retardation. Science 221: 376–378, 1983.
  • Seelig MS, Heggtveit HA: Magnesium interrelationships in ischemic heart disease: a review. Am J Clin Nutr 27: 59–79, 1974.
  • Seelig MS, Haddy FJ: Magnesium and the arteries: 1. Effects of magnesium deficiency on arteries and on the retention of sodium, potassium, and calcium. In Cartin M, Seelig MS (eds): “Magnesium in Health and Disease.” New York: Spectrum, pp 605–638, 1980.
  • Siegel G, Walter A, Gustavasson H, Lindman B: Magnesium and membrane function in vascular smooth muscle. Artery 9: 232–252, 1981.
  • Rayssiguier Y: Magnesium and lipid interrelationships in the pathogenesis of vascular diseases. Magnesium Bull 3: 165–177, 1981.
  • Rayssiguier Y: Role of magnesium and potassium in pathogenesis of atherosclerosis. In: “Proceedings of the International Symposium on Interactions of Magnesium and Potassium on Cardiac and Vascular Smooth Muscle.” Magnesium 3: 226–238, 1984.
  • Altura BM, Altura BT: Mg, Na and K interactions and coronary heart diseases. Magnesium 1: 241–265, 1982.
  • Altura BM, Altura BT: New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. Magnesium 4: 226–271, 1985.
  • Rayssiguier Y: New data on magnesium and lipid interrelationships in the pathogenesis of vascular diseases. In Halpern MJ, Durlach J (eds): “Magnesium Deficiency: Physiopathology and Treatment Implications.” Basel: Karger, pp 121–131, 1985.
  • Rayssiguier Y: Magnesium, lipids and vascular diseases. Experimental evidence in animal models. Magnesium 5: 182–190, 1986.
  • Rayssiguier Y, Gueux E: Magnesium and lipids in cardiovascular diseases. J Am Coll Nutr 5: 507–519, 1986.
  • Seelig MS: Cardiovascular consequences of magnesium deficiency and loss. Pathogenesis, prevalence, and manifestation, magnesium and chloride loss in refractory potassium repletions. Am J Cardiol 63: 4G–21G, 1989.
  • Haddy FJ, Seelig MS: Magnesium and the arteries: II. Physiologic effects of electrolyte abnormalities on arterial resistance. In Cartin M, Seelig MS (eds): “Magnesium in Health and Disease.” New York: Spectrum pp 639–657, 1980.
  • Seelig MS: Nutritional status and requirements of magnesium: with consideration of individual differences and prevention of cardiovascular disease. Magnesium Bull 8: 171–185, 1986.
  • Seelig MS: Human requirements in human nutrition. Magnesium Bull 3 (1a):26–47, 1981.
  • Seelig MS: Vitamin D and cardiovascular, renal and brain damage in infancy and childhood. Ann NY Acad Sci 147: 539–582, 1969.
  • Seelig MS: Are American children still getting an excess of vitamin D? Clin Pediatr 9: 380–383, 1970.
  • Kummerow FA, Cho BHS, Huang WYT, Imai K, Kamio A, Duetch MJ, Hooper WM: Additive risk factors in atherosclerosis. Am J Clin Nutr 29: 576–584, 1976.
  • Linden V: Correlation of vitamin D intake to ischemic heart disease, hypercholesterolemia, and renal calcinosis. In Seelig MS (ed): “Nutritional Imbalances in Infant and Adult Diseases.” New York: Spectrum, pp 23–42, 1977.
  • Taura S, Taura M, Imai H, Kummerow FA: Coronary atherosclerosis in normocholesterolemic swine. Artery 4: 395–407, 1978.
  • Kamio A, Kummerow FA, Imai H: Degeneration of aortic smooth muscle cells in swine fed excess vitamin D. Arch Pathol Lab Med 101: 378–381, 1977.
  • Toda T, Leszczynski DE, Kummerow FA: The role of 25-hydroxyvitamin D3 in the induction of atherosclerosis in swine and rabbit by hypervitaminosis D. Acta Pathol Jpn 33: 37–44, 1983.
  • National Research Council, National Academy of Science: “Nutrient Requirements of Swine,” 8th ed. Washington, DC: National Academy of Sciences, 1979.
  • Ito M, Cho BHS, Kummerow FA: Effects of a dietary magnesium deficiency and excess vitamin D3 on swine coronary arteries. J Am Coll Nutr 9: 155–163, 1990.
  • Seelig MS: Magnesium deficiency with phosphate and vitamin D excesses: role in pediatric cardiovascular disease? Cardiovasc Med 3: 637–650, 1978.
  • Daoud AS, Jarmolych J, Augustyn JM, Fritz KE, Singh JD, Lee KT: Regression of advanced atherosclerosis in swine. Arch Pathol Lab Med 100: 372–379, 1976.
  • Schroeder HA: Relation between hardness of water and death rates from certain chronic and degenerative diseases in the United States. J Chron Dis 12: 586–591, 1960.
  • Anderson TW, Le Riche WH, Mackay IS: Sudden death and ischemic heart disease. N Engl J Med 280: 805–807, 1969.
  • Durlach J, Bara M, Guiet-Bara A: Magnesium level in drinking water and its cardiovascular risk factor: a hypothesis. Magnesium 4: 5–15, 1985.
  • Karppanen H: Epidemiological studies on the relationship between magnesium intake and cardiovascular diseases. Artery 9: 190–199, 1981.
  • Marier JR: Magnesium content of the food supply in the modern day world. Magnesium 5: 1–8, 1986.
  • Morgan KJ, Stampley GL, Zabik ME, Fisher DR: Magnesium and calcium dietary intakes of the US population. J Am Coll Nutr 4: 195–206, 1985.
  • Dyckner T, Wester PO: Intracellular magnesium loss after diuretic administration. Drugs 28 (Suppl 1):161–166, 1984.
  • Flink EB: Hypomagnesemia in the patient receiving digitalis. Arch Intern Med 145: 624–625, 1985.
  • Hollifield JW: Magnesium depletion, diuretics, and arrhythmias. Am J Med 82 (3A):30–37, 1987.
  • Ryan MP, Devane J, Ryan MF, Counihan T: Effects of diuretics on the renal handling of magnesium. Drugs 28 (1):167–181, 1984.
  • Reyes AJ, Leary WP: Cardiovascular toxicity of diuretics related to magnesium depletion. Hum Toxicol 3: 351–371, 1984.
  • Whang R, Chrysant S, Dillard B, Smith W, Fryer A: Hypomagnesemia and hypokalemia in 1,000 treated ambulatory hypertensive patients. J Am Coll Nutr 1: 317–322, 1982.
  • Flink EB: Magnesium deficiency in alcoholism. Alcoholism Clin Exp Res 10: 590–594, 1986.
  • Back EH, Montgomery RD, Ward EE: Neurological manifestations of magnesium deficiency in infantile gastroenteritis and malnutrition. Arch Dis Child 37: 106–109, 1962.
  • Caddell J: Studies in protein-calorie malnutrition. II. A double-blind trial to assess magnesium therapy. N Engl J Med 276: 535–539, 1967.
  • Caddell J, Goddard DR: Studies in protein-calorie malnutrition II. Chemical evidence for magnesium deficiency. N Engl J Med 276: 533–535, 1967.
  • Flink EB, Brick JE, Shane SR: Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction. Arch Intern Med 141: 441–443, 1981.
  • Whang R, Flink EB: Glucose-insulin-potassium infusion in acute myocardial infarction—an overview. In Whang R (ed): “Potassium: Its Biological Significance.” Boca Raton, FL: CRC Press, pp 119–124, 1984.
  • Dickerson RN, Brown RO: Hypomagnesemia in hospitalized patients receiving nutritional support. Heart Lung 14: 561–569, 1985.
  • Kellaway G, Ewen K: Magnesium deficiency complications prolonged gastric suction. NZ Med J 61: 137–142, 1962.
  • Kagan A, Harris BR, Winkelstein W: Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chron Dis 27: 345–364, 1974.
  • Statistical Bureau of Management and Co-ordination Agency. Japan Statistical Yearbook. p 615, 1987.
  • See DS: Solar salt. In Kaufman DW (ed): “Sodium Chloride: The Production and Properties of Salt and Brine.” New York: Reinhold Publishing, pp 96–107, 1960.
  • Blackburn H: Risk factors and cardiovascular disease. In Dutton EP (ed): “The American Heart Association Heart-book.” New York: Am Heart Assoc, pp 2–20, 1980.
  • Statistical Bureau of Management and Co-ordination Agency. Japan Statistical Yearbook. pp 630–631, 1987.
  • Durlach J, Barra M, Guiet-Bara A: Magnesium and its relationship to oncology. In Sigel H, Sigel A (eds): “Metal Ions in Biological Systems (Vol 26); Compendium on Magnesium and its Role in Biology, Nutrition and Physiology.” New York: Marcel Dekker. pp 549–578, 1990.
  • Pitot HC, Dragon YP: Facts and theories concerning the mechanisms of carcinogenesis. FASEB J 5: 2280–2286, 1991.
  • Murray RK: Cancer, oncogenes and growth factors. In Murray RK, Granner DK, Mayes PA, Rodwell VW (eds): “Harper's Biochemistry.” 22nd ed. Norwalk, CT: Appleton and Lange, pp 650–662, 1990.
  • Henderson BE, Ross RK, Pike MC: Toward the primary prevention of cancer. Science 254: 1131–1138, 1991.
  • Miller EC: Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res 38: 1479–1496, 1978.
  • Guengerich FP: Reactions and significance of cytochrome P-450 enzymes. J Biol Chem 266: 10019–10022, 1991.
  • Matocha M, Wood R: Changes in host animal plasma lipids during hepatoma. Lipids 15: 421–427, 1980.
  • Henrotte JG: Recent advances on genetic factors regulating blood and tissue magnesium concentrations. Relationship with stress and immunity. In Itokawa Y, Durlach J (eds): “Magnesium in Health and Disease.” London: John Libbey, 1989.
  • Loughead JL, Mimouni F, Tsang RC, Koury JC: A role for magnesium in neonatal parathyroid gland function? J Am Coll Nutr 10: 123–126, 1991.
  • Durlach J: Magnesium depletion and pathogenesis of Alzheimer's disease. Magnesium Res 3: 217–218, 1990.
  • Seelig MS: Increased need for magnesium with the use of combined oestrogen and calcium for osteoporosis treatment. Magnesium Research 3: 197–215, 1990.
  • Altura BT, Altura BM: The role of magnesium in etiology of stroke and cerebrovasospasm. Magnesium 1: 277–291, 1982.
  • Durlach J: Neurological manifestations of magnesium imbalance. In Vinken P, Bruyn GW (eds): “Handbook of Clinical Neurology.” New York: North Holland, pp 545–579, 1976.
  • Durlach J, Durlach V: Idiopathic mitral valve prolapse and magnesium. State of the art. Magnesium Bull 8: 156–159, 1985.
  • Holmes RP, Kummerow FA: The relationship of adequate and excessive intake of vitamin D to health and disease. J Am Coll Nutr 2: 173–199, 1983.
  • Hulsmann WC, de Wit LEA, Dubleaar ML, Stam H: Substrates for energy metabolism in the heart: the role of the interstitial compartment. In Stam H, van der Vusse GJ (eds): “Lipid Metabolism in the Normoxic and Ischaemic Heart.” New York: Steinkopff Verlag Darmstadt, pp 3–10, 1987.
  • Calabrese EJ, Moore GS, Tuthill WR, Sieger TL: “Drinking Water and Cardiovascular Disease.” Park Forrest South, IL: Pathotoxic Publishers, 1980.
  • Singh RB, Mori H, Kummerow FA: Macro and trace minerals metabolism in coronary disease. Trace Elements in Medicine, in press.
  • Kummerow FA: Nutrition imbalance and angiotoxins as dietary risk factors in coronary heart disease. Am J Clin Nutr 32: 58–83, 1979.
  • Holman RT, Pusch F, Svingen B, Dutton HJ: Unusual isomeric polyunsaturated fatty acids in liver phospholipids of rats fed hydrogenated oil. Proc Natl Acad Sci USA 88: 4830–4834, 1991.
  • Mensink RP, Katan MB: Effect of dietary trans fatty acids on high-density and low density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 323: 439–445, 1990.
  • Holman RT, Johnson SB, Ogburn PL: Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci USA 88: 4835–4839, 1991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.